NBM200

Noninvasive hemoglobin monitor · OrSense, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBM200, covering 2013-08-07 to 2013-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients